1 completed, 1 recruiting, 1 suspended. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Suspended 1 |
| Phase 2 | 1 | Completed 1 |
Follow BARD1 Gene Mutation: new trials by email Literature Review of BARD1 Gene Mutation trials Research Report on BARD1 Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results Intervention Arm At-risk Relative/ARR Contacts, MyGene Portal, Standard of Care - BRCA1 Mutation, POLD1 Gene Mutation | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 1000 | 2022-12-01 | 2026-08-27 |
| Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) Educational Intervention, Genetic Counseling, Laboratory Biomarker Analysis - BARD1 Gene Mutation, BRCA1 Gene Mutation | Not applicable | Suspended | M.D. Anderson Cancer Center | 5200 | 2017-04-18 | 2026-08-26 |
| Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer Laboratory Biomarker Analysis, Pharmacological Study, Talazoparib - ATM Gene Mutation, ATR Gene Mutation | Phase 2 | Completed | SWOG Cancer Research Network | 51 | 2017-03-03 | 2021-06-23 |
Triple Negative Breast Neoplasms (1)
Breast Diseases (1) · Breast Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Early Intervention, Educational (1) · Educational Status (1) · Genetic Counseling (1) · Methods (1) · Standard of Care (1) · talazoparib (1)
M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · SWOG Cancer Research Network (1)
United States (3) · Canada (1)
Kenneth Offit, MD, MPH (1) · Roni Wilke (1) · Vassiliki Papadimitrakopoulou (1)
PMID 31266460, PMID 36155347, PMID 37707822
U10CA180888 (1)